Not provided
Not provided
Not provided
Not provided
Not provided
change in practice occured
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to investigate clinical outcomes from two current standard of care pain control procedures performed for patients undergoing pacemaker insertion.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Superficial Cervical Plexus Block | Active Comparator |
| |
| Local Infiltration | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Superficial Cervical Plexus Block (SCP) block | Procedure | SCP block using 10-15ml of 1% Ropivacaine |
|
| Measure | Description | Time Frame |
|---|---|---|
| To decrease opioid requirements after Pacemaker insertion | first 24 hrs post pacemaker insertion |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Christopher Robards, MD | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic | Jacksonville | Florida | 32224 | United States |
Not provided
| ID | Term |
|---|---|
| D010146 | Pain |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D054832 | Urocortins |
| D003766 | Dental Occlusion |
| ID | Term |
|---|---|
| D036361 | Peptide Hormones |
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
| D009479 | Neuropeptides |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Local site infiltration | Procedure | Local site infiltration using 2% lidocaine |
|
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |
| D003813 | Dentistry |
| D009063 | Dental Physiological Phenomena |
| D055688 | Digestive System and Oral Physiological Phenomena |